Opportunistic infection outcomes in patients receiving corticosteroids for immune checkpoint inhibitor toxicity

被引：0
|
作者：
Cook, Michael [1 ]
Atkins, Michael [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P722
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Monitoring of thyroid function tests in patients receiving immune checkpoint inhibitor therapy
    Slattery, Timothy
    Sacks, Lori
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 24 - 24
  • [32] Renal Vasculitis and Pauci-immune Glomerulonephritis in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Gallan, Alexander
    Alexander, Ellen
    Chang, Anthony
    Henriksen, Kammi
    MODERN PATHOLOGY, 2019, 32
  • [33] Renal Vasculitis and Pauci-immune Glomerulonephritis in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Gallan, Alexander
    Alexander, Ellen
    Chang, Anthony
    Henriksen, Kammi
    LABORATORY INVESTIGATION, 2019, 99
  • [34] Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team
    Ito, Takanori
    Mizuno, Kazuyuki
    Yamamoto, Takafumi
    Yasuda, Tsukasa
    Yokoyama, Shinya
    Yamamoto, Kenta
    Imai, Norihiro
    Ishizu, Yoji
    Honda, Takashi
    Hama, Masayo
    Kataoka, Tomomi
    Shimokata, Tomoya
    Ando, Yuichi
    Kawashima, Hiroki
    HEPATOLOGY RESEARCH, 2024, 54 (11) : 1060 - 1069
  • [35] INCIDENCE OF IMMUNE CHECKPOINT INHIBITOR RELATED GI TOXICITY IN PATIENTS WITH GI LUMINAL MALIGNANCY AND OUTCOMES AFTER TREATMENT
    Yu, Kevin
    Abraham, Fiyinfoluwa
    Thomas, Anusha Shirwaikar
    Wang, Yinghong
    GASTROENTEROLOGY, 2021, 160 (06) : S52 - S53
  • [36] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Sophia Bylsma
    Karen Yun
    Sandip Patel
    Michael J Dennis
    Current Treatment Options in Oncology, 2022, 23 : 1153 - 1168
  • [37] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Bylsma, Sophia
    Yun, Karen
    Patel, Sandip
    Dennis, Michael J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1153 - 1168
  • [38] At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity
    Young, Arabella
    Bluestone, Jeffrey A.
    CANCER DISCOVERY, 2021, 11 (03) : 537 - 539
  • [39] Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma
    Aslan, Volkan
    Kilic, Atiye Cenay Karabork
    Sutcuoglu, Osman
    Eraslan, Emrah
    Bayrak, Ahmet
    Oksuzoglu, Berna
    Tahtaci, Gozde
    Ozdemir, Nuriye
    Uner, Aytug
    Gunel, Nazan
    Ozet, Ahmet
    Yazici, Ozan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) : 494.e1 - 494.e10
  • [40] The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy
    Tsung-Han Tsai
    Po-Jung Su
    Shih-Yu Huang
    Ming-Chun Kuo
    Chang-Ting Lin
    Chia-Che Wu
    Hao-Lun Luo
    Chien-Hsu Chen
    Chih-Chi Chou
    Ting-Ting Liu
    Chun-Chieh Huang
    Kai-Lung Tsai
    Yu-Li Su
    BMC Cancer, 23 (1)
12345